222 related articles for article (PubMed ID: 15317552)
1. Rate of nosocomial transmission of vancomycin-resistant enterococci from isolated patients.
Cheng AC; Harrington G; Russo P; Liolios L; Spelman D
Intern Med J; 2004 Aug; 34(8):510-2. PubMed ID: 15317552
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant enterococci (VRE): transmission and control.
Tacconelli E; Cataldo MA
Int J Antimicrob Agents; 2008 Feb; 31(2):99-106. PubMed ID: 18164908
[TBL] [Abstract][Full Text] [Related]
3. Control of vancomycin-resistant enterococci in a hospital: a five-year experience in a Taiwanese teaching hospital.
Wang JT; Chen YC; Chang SC; Chen ML; Pan HJ; Chang YY; Sun CC; Wang LH; Wang SH; Lin HC; Chien SF; Tseng MS
J Hosp Infect; 2004 Oct; 58(2):97-103. PubMed ID: 15474179
[TBL] [Abstract][Full Text] [Related]
4. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital.
Calfee DP; Giannetta ET; Durbin LJ; Germanson TP; Farr BM
Clin Infect Dis; 2003 Aug; 37(3):326-32. PubMed ID: 12884155
[TBL] [Abstract][Full Text] [Related]
5. Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital.
Lucet JC; Armand-Lefevre L; Laurichesse JJ; Macrez A; Papy E; Ruimy R; Deblangy C; Lozach A; Lolom I; Jarlier V; Andremont A; Leport C
J Hosp Infect; 2007 Sep; 67(1):42-8. PubMed ID: 17719129
[TBL] [Abstract][Full Text] [Related]
6. Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit.
Peta M; Carretto E; Barbarini D; Zamperoni A; Carnevale L; Perversi L; Pagani M; Bonora MG; Fontana R; Marone P; Langer M
Clin Microbiol Infect; 2006 Feb; 12(2):163-9. PubMed ID: 16441455
[TBL] [Abstract][Full Text] [Related]
7. Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units.
Perencevich EN; Fisman DN; Lipsitch M; Harris AD; Morris JG; Smith DL
Clin Infect Dis; 2004 Apr; 38(8):1108-15. PubMed ID: 15095215
[TBL] [Abstract][Full Text] [Related]
8. Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible.
Morris-Downes M; Smyth EG; Moore J; Thomas T; Fitzpatrick F; Walsh J; Caffrey V; Morris A; Foley S; Humphreys H
J Hosp Infect; 2010 Jul; 75(3):228-33. PubMed ID: 20363048
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre.
Shaikh ZH; Osting CA; Hanna HA; Arbuckle RB; Tarr JJ; Raad II
J Hosp Infect; 2002 May; 51(1):52-8. PubMed ID: 12009821
[TBL] [Abstract][Full Text] [Related]
10. Transfer of vancomycin-resistant enterococci via health care worker hands.
Duckro AN; Blom DW; Lyle EA; Weinstein RA; Hayden MK
Arch Intern Med; 2005 Feb; 165(3):302-7. PubMed ID: 15710793
[TBL] [Abstract][Full Text] [Related]
11. The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital.
Kritsotakis EI; Christidou A; Roumbelaki M; Tselentis Y; Gikas A
Clin Microbiol Infect; 2008 Aug; 14(8):747-54. PubMed ID: 18727798
[TBL] [Abstract][Full Text] [Related]
12. [VCA agar (bioMérieux) for selective isolation of vancomycin-resistant Enterococci (VRE) from fecal specimens].
Delmas J; Robin F; Romaszko JP; Baraduc R; Lesens O; Sirot J; Bonnet R
Pathol Biol (Paris); 2005; 53(8-9):485-9. PubMed ID: 16084029
[TBL] [Abstract][Full Text] [Related]
13. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci.
Sakka V; Tsiodras S; Galani L; Antoniadou A; Souli M; Galani I; Pantelaki M; Siafakas N; Zerva L; Giamarellou H
Clin Microbiol Infect; 2008 Jan; 14(1):14-21. PubMed ID: 18005178
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiologic increase of various genotypes of vancomycin-resistant Enterococcus faecium in a university hospital].
Mascini EM; Gigengack-Baars AC; Hené RJ; Kamp-Hopmans TE; Weersink AJ; Bonten MJ
Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2572-6. PubMed ID: 11191796
[TBL] [Abstract][Full Text] [Related]
15. Control of vancomycin-resistant enterococci in the neonatal intensive care unit.
Singh N; Léger MM; Campbell J; Short B; Campos JM
Infect Control Hosp Epidemiol; 2005 Jul; 26(7):646-9. PubMed ID: 16092746
[TBL] [Abstract][Full Text] [Related]
16. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci.
Hayden MK
Clin Infect Dis; 2000 Oct; 31(4):1058-65. PubMed ID: 11049790
[TBL] [Abstract][Full Text] [Related]
17. Control of vancomycin-resistant enterococci: one size fits all?
Armeanu E; Bonten MJ
Clin Infect Dis; 2005 Jul; 41(2):210-6. PubMed ID: 15983917
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak.
Beltrami EM; Singer DA; Fish L; Manning K; Young S; Banerjee SN; Baker R; Jarvis WR
Am J Infect Control; 2000 Aug; 28(4):282-5. PubMed ID: 10926704
[TBL] [Abstract][Full Text] [Related]
19. The impact of persistent gastrointestinal colonization on the transmission dynamics of vancomycin-resistant enterococci.
D'Agata EM; Horn MA; Webb GF
J Infect Dis; 2002 Mar; 185(6):766-73. PubMed ID: 11920294
[TBL] [Abstract][Full Text] [Related]
20. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia.
Price CS; Paule S; Noskin GA; Peterson LR
Clin Infect Dis; 2003 Oct; 37(7):921-8. PubMed ID: 13130403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
